SAFE, VERSATILE AND EASY TO USE
The world’s only system for on-site preparation of autologous fibrin sealant and Platelet Rich Fibrin (PRF®). It provides a range of safe, versatile and user-friendly products for a great number of clinical applications.
The uniqueness of the Vivostat® system is a novel patented biotechnological process that enables reliable and reproducible preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF®) without using cryoprecipitation and without the need for a separate thrombin component.
Fast growing company
Engaged in developing
Innovative solutions
INFORMATION
ABOUT THE PRODUCT
AUTOLOGOUS BIOLOGICAL MATERIAL
The uniqueness of the Vivostat®_ preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF®) without using cryoprecipitation and without the need for a separate thrombin component.
_____________________________________________
MEDICAL PROFESSIONALS
Vivostat® has a product that can help overcome challenges with: HAEMOSTASIS, SEALING, GLUING or REGENERATION OF TISSUE.
THREE COMPONENTS ARE ENOUGH
The fully automated Vivostat® system consists of three components: Processor Unit, Applicator Unit, The Disposable Set
__________________________________
A REVOLUTION IN FIBRIN SEALANT TECHNOLOGY
The fully automated Vivostat® system prepares 5-6 ml of autologous fibrin sealant from 120 ml of the patient’s own blood in approx. 24 minutes.
PRODUCTS
THE VIVOSTAT® SYSTEM
APPLICATION DEVICES
VIVOSTAT® FIBRIN SEALANT
VIVOSTAT PRF®
MEDICAL PROFESSIONALS
The Vivostat® product line can be used in a wide range of surgical procedures and environments. In the left hand menu you will find the most common areas of use for Vivostat®
ABDOMINAL SURGERY
BURNS SURGERY
CARDIAC SURGERY
NEURO SURGERY
ORTHOPAEDIC SURGERY
THORACIC SURGERY
VASCULAR SURGERY
WOUND SURGERY
MISSION AND VISION
MISSION
Support soft tissue healing following medical treatment by enhancing the body’s own capabilities
VISION
Vivostat wants to be a preferred supplier of solutions offering enhanced healing through autologous blood derived products and improved outcomes through combination treatments